Intra-Cellular Therapies total non-operating income/expense for the twelve months ending December 31, 2024 was $0.050B, a 41.25% increase year-over-year.
Intra-Cellular Therapies annual total non-operating income/expense for 2024 was $0.043B, a 0% decline from 2024.
Intra-Cellular Therapies annual total non-operating income/expense for 2024 was $0.043B, a 109.01% increase from 2023.
Intra-Cellular Therapies annual total non-operating income/expense for 2023 was $0.02B, a 0% decline from 2023.
Intra-Cellular Therapies Total Non-Operating Income/Expense 2013-2024 | ITCI